BLCA tumors with high expression of KLRK1, which encodes the activating NKG2D receptor, had a much improved prognosis compared with BLCA patients with low tumor expression of KLRK1 (Figure 5A). Here, KLRK1 is linked to bladder transitional cell carcinoma.